Timing of Target Enteral Feeding in the Mechanically Ventilated Patient

December 16, 2013 updated by: Todd Rice, Vanderbilt University

Phase III Study of Early vs. Delayed Goal Enteral Nutrition in Mechanically Ventilated Patients

This study tests the hypothesis that initial trophic enteral feedings will increase the time alive and free of mechanical ventilation as compared to initial goal enteral feedings in patients who are mechanically ventilated.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Mechanically ventilated patients, within 48 hours of initiating mechanical ventilation, are randomized in a 1:1 fashion to receive trophic enteral feedings for 96 hours followed by advancement to goal feeding rates or initial advancement to goal feeding rates. Primary endpoints are ventilator free days, ICU-free days, gastrointestinal intolerances, development of nosocomial infections, and mortality.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: Patients will be eligible for inclusion in the study if they meet the following criteria:

  • Mechanical ventilation expected to last at least 72 hours.
  • Presence of, or primary physician's intent to place, an enteral feeding tube and begin enteral feeds.

Exclusion Criteria:

  • More than 48 hours elapsed since both inclusion criteria met.
  • Patient, legal representative, or physician refuses consent or is unavailable to provide consent.
  • Patient, legal representative, or physician not committed to full support (Exception: A patient will not be excluded if he/she would receive all supportive care except for attempts at resuscitation from cardiac arrest).
  • Presence of malignant or irreversible condition and estimated 28 day mortality greater than 50%.
  • Severe or refractory shock.
  • Moribund patients not expected to survive 24 hours from start of enteral feeding (as determined by primary medical team).
  • Child-Pugh score greater than 10.
  • Presence of partial or complete mechanical bowel obstruction, or ischemia, or infarction.
  • Current TPN use or intent to use TPN within 7 days.
  • Severe malnutrition with BMI less than 18.5 and/or loss of more than 30% total body weight in the previous 6 months.
  • Neuromuscular disease impairing the ability to ventilate spontaneously.
  • Laparotomy expected within 7 days.
  • Unable to raise head of bed 45°.
  • greater than 30% total body surface area burns.
  • Absence of GI tract/short bowel syndrome - defined as entire length of small bowel totaling 4 feet or less.
  • Presence of high-output (> 500 cc/day) enterocutaneous fistula.
  • Age less than 13 years
  • Allergy to enteral formula

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
trophic feeds
10cc/hr
Active Comparator: 2
Full-calorie feeds
10cc/hr

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Ventilator-free days
Time Frame: day 28
day 28

Secondary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: 28 days
28 days
ICU-free days
Time Frame: day 28
day 28
Incidence of Gastrointestinal intolerances
Time Frame: day 14
day 14
Organ failure-free days
Time Frame: day 28
day 28
Changes in inflammation as measured by serum cytokine levels
Time Frame: baseline vs. days 6 and 12
baseline vs. days 6 and 12
Changes in levels of nutrition as measured by serum albumin, total protein, and pre-albumin
Time Frame: baseline vs. days 6 or 12
baseline vs. days 6 or 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Todd W Rice, MD, MSc, Vanderbilt University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2003

Primary Completion (Actual)

October 1, 2009

Study Completion (Actual)

October 1, 2009

Study Registration Dates

First Submitted

November 9, 2005

First Submitted That Met QC Criteria

November 10, 2005

First Posted (Estimate)

November 11, 2005

Study Record Updates

Last Update Posted (Estimate)

December 17, 2013

Last Update Submitted That Met QC Criteria

December 16, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe